Wednesday May 15 | BioSpace
Metformin Won't Aid Breast Cancer Survival in Diabetics, Women's College Hospital Study
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Despite prior research suggesting that the widely used diabetes drug metformin might help cancer patients, a new study finds it does not boost survival for older breast cancer patients with diabetes.
Wednesday May 15 | Newsday
Metformin Won't Aid Breast Cancer Survival in Diabetics
In Eastport accident on CR-51/East Moriches Riverhead Rd at Eastport Manor Rd. Slow traffic from Rt-27/Sunrise Hwy in Suffolk In Eastport accident on CR-51/East Moriches Riverhead Rd at Eastport Manor Rd.
Despite Earlier Claims, Metformin Not Found To Improve Survival Rates After Cancer
Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates after breast cancer in certain patients.
Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction.
Metformin-mediated growth inhibition involves suppression of the...
Epidemiological studies have shown direct associations between type 2 diabetes and obesity, both conditions associated with hyperglycaemia and hyperinsulinemia, and the risk of pancreatic cancer.
Metformin May Delay Aging Process
The oral diabetes drug metformin may slow the aging process by mimicking the effects of a calorie-restricted diet, according to a new animal study from the United Kingdom.
Popular diabetes drug does not improve survival rates after cancer: Study
Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates after breast cancer in certain patients.
Diabetes Drug Makes Lung Cancer Vulnerable To Radiotherapy
THE DIABETES drug metformin slows the growth of lung cancer cells and makes them more likely to be killed by radiotherapy, according to a study published in the British Journal of Cancer this week.
Diabetes drug makes lung cancer vulnerable to radiotherapy
The diabetes drug metformin slows the growth of lung cancer cells and makes them more likely to be killed by radiotherapy, according to a study published in the British Journal of Cancer today.
Saxagliptin/Metformin Combination: Added Benefit Is Not Proven
The fixed combination of the drugs saxagliptin and metformin has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus.
Merck, Pfizer Form Diabetes Pact
Merck and Pfizer have entered into a worldwide collaboration for the development and commercialization of Pfizer's ertugliflozin , an investigational oral sodium glucose cotransporter inhibitor for the treatment of type 2 diabetes.
Medical ID Bracelets Really Helps EMS to Avoid Misdiagnosis In A Medical Emergency
People with chronic medical conditions who wear a medical identification bracelet are making a simple decision that could save their life in an emergency.
FDA grants tentative approval to two Sun generics
The Food and Drug Administration has given tentative approval to two generic diabetes drugs made by Sun Pharmaceutical Industries, the Indian drug maker said.